Madam Chair, as Minister Hajdu indicated previously, Minister Anand will be appearing before the committee. We have to respond very specifically. We have a very significant amount of information up on the Canada.ca coronavirus website.
I would indicate further that in regard to the regulatory decisions, a scientific summary basis of decision is posted. Further to our strong commitment to transparency, the product monograph, further information on the authorization and the clinical data associated with the development of the vaccines will also be posted.